VITASPRING BIOMEDICAL CO., LTD. Income (Loss) from Continuing Operations before Income Taxes, Domestic
VITASPRING BIOMEDICAL CO., LTD. (VSBC) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $183.58 thousand for the 3-month period ending 2022-10-31, per its 10-Q filed 2022-12-21.
Discontinued › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2022-12-21
- VITASPRING BIOMEDICAL CO., LTD. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2022-10-31 was $183.58K, a 33.56% increase year-over-year.
- VITASPRING BIOMEDICAL CO., LTD. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2022-07-31 was $174.46K.
- VITASPRING BIOMEDICAL CO., LTD. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2022-04-30 was $351.65K, a 96.00% increase year-over-year.
- VITASPRING BIOMEDICAL CO., LTD. income (loss) from continuing operations before income taxes, domestic for the quarter ending 2022-01-31 was $503.76K.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 3 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 6 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 9 month | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|---|---|---|
| 2022-10-31 | $183.58K 10-Q · filed 2022-12-21 | $358.04K derived: sum of 2 quarters · filed 2022-12-21 | $6.67K 10-Q · filed 2022-12-21 | $1.21M derived: sum of 4 quarters · filed 2022-12-21 |
| 2022-07-31 | $174.46K 10-Q · filed 2022-09-15 | -$177.19K 10-Q · filed 2022-09-15 | $1.03M derived: sum of 3 quarters · filed 2022-12-21 | $1.17M derived: sum of 4 quarters · filed 2022-12-21 |
| 2022-04-30 | $351.65K 10-Q · filed 2022-06-15 | $855.41K derived: sum of 2 quarters · filed 2022-12-21 | $992.86K derived: sum of 3 quarters · filed 2022-12-21 | $741.98K derived: sum of 4 quarters · filed 2022-12-21 |
| 2022-01-31 | $503.76K derived: 10-Q 12 month − 10-Q 9 month · filed 2022-12-21 | $641.21K derived: sum of 2 quarters · filed 2022-12-21 | $390.33K derived: sum of 3 quarters · filed 2022-12-21 | $210.92K 10-Q · filed 2022-12-21 |
| 2021-10-31 | $137.45K 10-Q · filed 2022-12-21 | -$113.42K derived: sum of 2 quarters · filed 2022-12-21 | -$292.83K 10-Q · filed 2022-12-21 | |
| 2021-07-31 | -$250.88K 10-Q · filed 2022-09-15 | -$430.29K 10-Q · filed 2022-09-15 | ||
| 2021-04-30 | $179.41K 10-Q · filed 2022-06-15 |